title: Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats.
abstract: Nerve growth factor (NGF) has been proposed as an important mediator inducing bladder overactivity under pathological conditions such as spinal cord injury, bladder outlet obstruction, or cystitis. We therefore examined the effects of chronic NGF treatment on bladder activity and the properties of bladder afferent neurons. In adult female rats, NGF (2.5 microg/microl) was infused continuously into the intrathecal space at the L6-S1 level of spinal cord for 1 or 2 weeks using osmotic pumps (0.5 microl/h). Bladder afferent neurons were labeled with axonal transport of Fast Blue injected into the bladder wall. After intrathecal injection of NGF, cystometrograms under an awake condition showed bladder overactivity revealed by time-dependent reductions in intercontraction intervals and voided volume. ELISA analyses showed significant increases in NGF levels in L6-S1 dorsal root ganglia of NGF-treated rats. In patch-clamp recordings, dissociated bladder afferent neurons exhibiting tetrodotoxin (TTX)-resistant action potentials from NGF-treated animals were larger in diameter and had significantly lower thresholds for spike activation compared with sham rats. In addition, the number of TTX-resistant action potentials during 600 ms depolarizing pulses was significantly increased time dependently after 1 or 2 weeks of NGF application. The density of slowly inactivating A-type K+ currents was decreased by 52% in bladder afferent neurons with TTX-resistant spikes after 2 week NGF treatment. These results indicate that increased NGF levels in bladder afferent pathways and NGF-induced reduction in A-type K+ current density could contribute to the emergence of bladder overactivity as well as somal hypertrophy and hyperexcitability of bladder afferent neurons.
authors.affiliation: Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA. nyos@pitt.edu
authors.forename: Naoki
authors.initials: N
authors.lastname: Yoshimura
authors.forename: Nelson E
authors.initials: NE
authors.lastname: Bennett
authors.forename: Yukio
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Teruyuki
authors.initials: T
authors.lastname: Ogawa
authors.forename: Osamu
authors.initials: O
authors.lastname: Nishizawa
authors.forename: Michael B
authors.initials: MB
authors.lastname: Chancellor
authors.forename: William C
authors.initials: WC
authors.lastname: de Groat
authors.forename: Satoshi
authors.initials: S
authors.lastname: Seki
mesh_terms: D000818:Animals; D005260:Female; D007278:Injections, Spinal; D020932:Nerve Growth Factor / Q000008:administration & dosage* / Q000502:physiology*; D009475:Neurons, Afferent / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D001743:Urinary Bladder / Q000502:physiology*; D014549:Urinary Incontinence / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D020932:Nerve Growth Factor